8-K 1 f97173e8vk.htm FORM 8-K e8vk
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
_________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 8, 2004

LIPID SCIENCES, INC.

(Exact name of registrant as specified in its charter)
         
Delaware   0-497   43-0433090
  		 
  		 
 
(State or other
jurisdiction of
incorporation) 		  (Commission File
Number) 		  (I.R.S Employer
Identification No.)
     
7068 Koll Center Parkway, Suite 401, Pleasanton, California   94566
  		 
 
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (925) 249-4000

 

TABLE OF CONTENTS

Item 5. Other Events and Regulation FD Disclosure
Item 7. Financial Statements and Exhibits
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1

Table of Contents

Item 5. Other Events and Regulation FD Disclosure

     On March 8, 2004, Lipid Sciences, Inc., a Delaware corporation, issued a press release entitled “Lipid Sciences, Inc. Announces Election of Bosko Djordjevic as Director.” The press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

Item 7. Financial Statements and Exhibits

     (c) Exhibits

     
Exhibit
   Description
99.1
  Lipid Sciences, Inc. Press Release dated March 8, 2004

 

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
  Lipid Sciences, Inc.
 
    
Date: March 8, 2004
  By: /s/ Sandra Gardiner
 
 
  Name: Sandra Gardiner
Title: Chief Accounting Officer

 

Table of Contents

EXHIBIT INDEX

     
Exhibit
   Description
99.1
  Lipid Sciences, Inc. Press Release dated March 8, 2004